文献速递系统性红斑狼疮

抗疟药对狼疮患者具有心脏保护作用:西班牙风湿病学会狼疮登记处(RELESSER)分析中与心力衰竭相关的因素

Antimalarials exert a cardioprotective effect in lupus patients: Insights from the Spanish Society of Rheumatology Lupus Register (RELESSER) analysis of factors associated with heart failure.
PubMed 文献 · Semin Arthritis Rheum · 2022-01-02

横断面研究纳入西班牙风湿病学会狼疮登记处(RELESSER)中117例合并慢性心力衰竭(CHF)的系统性红斑狼疮(SLE)患者与3506例SLE对照,多因素分析显示缺血性心脏病、心律失常、肺动脉高压、瓣膜病、非心血管损伤及钙/维生素D治疗与CHF相关,女性与抗疟药使用为保护因素,提示抗疟药似乎具有心脏保护作用。

要点

  • 合并CHF的SLE患者病情更重、器官损伤更多、死亡率更高。
  • 抗疟药使用与CHF风险降低相关(0.28 [0.17-0.45],p < 0.000)。
  • 女性与CHF风险降低相关(0.46 [0.25-0.88],p = 0.0147)。

核心结论

  • 合并CHF的SLE患者经历更严重的SLE,抗疟药治疗似乎具有心脏保护作用。

研究设计与样本

  • 横断面研究,纳入西班牙风湿病学会狼疮登记处(RELESSER)中符合ACR-1997标准的全部SLE患者,基于历史收集数据,排除SLE诊断前已患CHF者。
  • 研究人群包括117例合并CHF的SLE患者(ACR-97标准)和3506例SLE对照,其中90%为女性。

主要发现

  • 合并CHF的患者较无CHF者年龄更大,SLE严重程度、器官损伤和死亡率更高。
  • 多变量模型显示与CHF相关的因素包括缺血性心脏病(7.96 [4.01-15.48],p < 0.0001)、心律失常(7.38 [4.00-13.42],p < 0.0001)、肺动脉高压(3.71 [1.84-7.25],p < 0.0002)、瓣膜病(6.33 [3.41-11.62],p < 0.0001)、非心血管损伤(1.29 [1.16-1.44],p < 0.000)及钙/维生素D治疗(5.29 [2.07-16.86],p = 0.0015)。
  • 女性(0.46 [0.25-0.88],p = 0.0147)和抗疟药(0.28 [0.17-0.45],p < 0.000)为保护因素。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND/OBJECTIVES: Factors associated with chronic heart failure (CHF) in patients with systemic lupus erythematosus (SLE) have received little attention. Recent data on the use of hydroxychloroquine in the treatment of SARS-CoV-2 infection have cast doubt on its cardiac safety. The factors associated with CHF, including therapy with antimalarials, were analyzed in a large multicenter SLE cohort. METHODS: Cross-sectional study including all patients with SLE (ACR-1997 criteria) included in the Spanish Society of Rheumatology Lupus Register (RELESSER), based on historically gathered data. Patients with CHF prior to diagnosis of SLE were excluded. A multivariable analysis exploring factors associated with CHF was conducted. RESULTS: The study population comprised 117 patients with SLE (ACR-97 criteria) and CHF and 3,506 SLE controls. Ninety percent were women. Patients with CHF were older and presented greater SLE severity, organ damage, and mortality than those without CHF. The multivariable model revealed the factors associated with CHF to be ischemic heart disease (7.96 [4.01-15.48], p < 0.0001), cardiac arrhythmia (7.38 [4.00-13.42], p < 0.0001), pulmonary hypertension (3.71 [1.84-7.25], p < 0.0002), valvulopathy (6.33 [3.41-11.62], p < 0.0001), non-cardiovascular damage (1.29 [1.16-1.44], p < 0.000) and calcium/vitamin D treatment (5.29 [2.07-16.86], p = 0.0015). Female sex (0.46 [0.25-0.88], p = 0.0147) and antimalarials (0.28 [0.17-0.45], p < 0.000) proved to be protective factors. CONCLUSIONS: Patients with SLE and CHF experience more severe SLE. Treatment with antimalarials appears to confer a cardioprotective effect.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Rúa-Figueroa I, Rúa-Figueroa D, Pérez-Veiga N, et al. Antimalarials exert a cardioprotective effect in lupus patients: Insights from the Spanish Society of Rheumatology Lupus Register (RELESSER) analysis of factors associated with heart failure. Semin Arthritis Rheum. 2022. PMID: 35033377. doi:10.1016/j.semarthrit.2021.11.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。